NEUROVIRT LIMITED

No Analysis Available

Get instant AI-powered insights about this company's financial health, risks, and trends.

Order Analysis - £10
Legal registered address
5 Elstree Gate Elstree Way Borehamwood Hertfordshire United Kingdom WD6 1JD Copied!

Latest financial results as of 3 September 2025
Current assets
£489.23k
Fixed assets
£34.03k
Current creditors
£190.42k
Shareholders funds
£332.84k
View full financial accounts

Company number
12528015 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
Micro
Incorporated on
20 March 2020
Accounts

Latest annual accounts were to 31 March 2024

Next annual accounts are due by 31 December 2025

Company financial year end is on 31 March 2026

Confirmation statement

Latest confirmation statement statement dated 14 October 2024

Next statement due by 28 October 2025

View original and historic source data
Nature of business (SIC)

72110 - Research and experimental development on biotechnology

86900 - Other human health activities

Latest company documents
DateDescription
03/02/253 February 2025 Change of share class name or designation

View Document

03/02/253 February 2025 Cancellation of shares. Statement of capital on 2025-01-20

View Document

03/02/253 February 2025 Purchase of own shares.

View Document

24/01/2524 January 2025 Memorandum and Articles of Association

View Document

24/01/2524 January 2025 Resolutions

View Document

View all company documents
AI-Powered Analysis for NEUROVIRT LIMITED

Get instant insights with Claude AI. Ask questions like:

  • "Is NEUROVIRT LIMITED financially stable?"
  • "What are the key risks for lending to this company?"
  • "Show me the director history and red flags"
Set Up AI Assistant

Takes 60 seconds • Works with Claude.ai


More Company Information

AI Company Analysis

Ask Claude AI about NEUROVIRT LIMITED:


Start Free Setup →

No downloads • 60 second setup


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company